EA200101131A1 - Суспензия зипразидона - Google Patents

Суспензия зипразидона

Info

Publication number
EA200101131A1
EA200101131A1 EA200101131A EA200101131A EA200101131A1 EA 200101131 A1 EA200101131 A1 EA 200101131A1 EA 200101131 A EA200101131 A EA 200101131A EA 200101131 A EA200101131 A EA 200101131A EA 200101131 A1 EA200101131 A1 EA 200101131A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ziprazidona
suspension
ziprasidone
polysorbate
suspended
Prior art date
Application number
EA200101131A
Other languages
English (en)
Other versions
EA003907B1 (ru
Inventor
Даниел Рэй Аренсон
Хонг Кви
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22472103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200101131(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200101131A1 publication Critical patent/EA200101131A1/ru
Publication of EA003907B1 publication Critical patent/EA003907B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Dental Preparations (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

Композиции, включающие свободное основание зипразидона или трудносмачиваемую фармацевтически приемлемую кислотно-аддитивную соль зипразидона, полисорбат и коллоидный диоксид кремния, образуют хорошие водные суспензии, имеющие полезный срок службы и легко повторно суспендируются, если происходит осаждение.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200101131A 1999-05-27 2000-05-08 Композиция зипразидона в виде суспензии EA003907B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13626899P 1999-05-27 1999-05-27
PCT/IB2000/000593 WO2000072847A1 (en) 1999-05-27 2000-05-08 Ziprasidone suspension

Publications (2)

Publication Number Publication Date
EA200101131A1 true EA200101131A1 (ru) 2002-04-25
EA003907B1 EA003907B1 (ru) 2003-10-30

Family

ID=22472103

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101131A EA003907B1 (ru) 1999-05-27 2000-05-08 Композиция зипразидона в виде суспензии

Country Status (50)

Country Link
EP (1) EP1181018B1 (ru)
JP (1) JP3942827B2 (ru)
KR (1) KR100477782B1 (ru)
CN (1) CN1196486C (ru)
AP (1) AP1409A (ru)
AR (1) AR022643A1 (ru)
AT (1) ATE234097T1 (ru)
AU (1) AU777413B2 (ru)
BG (1) BG65367B1 (ru)
BR (1) BR0010990A (ru)
CA (1) CA2371550C (ru)
CO (1) CO5170458A1 (ru)
CR (1) CR6506A (ru)
CU (1) CU23223B7 (ru)
CZ (1) CZ20014230A3 (ru)
DE (1) DE60001649T2 (ru)
DK (1) DK1181018T3 (ru)
DZ (1) DZ3049A1 (ru)
EA (1) EA003907B1 (ru)
EE (1) EE04704B1 (ru)
ES (1) ES2191618T3 (ru)
GC (1) GC0000190A (ru)
GE (1) GEP20033113B (ru)
GT (1) GT200000081A (ru)
HK (1) HK1046366B (ru)
HN (1) HN2000000071A (ru)
HR (1) HRP20010878B1 (ru)
HU (1) HUP0201297A3 (ru)
IL (2) IL145950A0 (ru)
IS (1) IS2396B (ru)
MA (1) MA26741A1 (ru)
MX (1) MXPA01012124A (ru)
MY (1) MY127891A (ru)
NO (1) NO320296B1 (ru)
NZ (1) NZ514764A (ru)
OA (1) OA11946A (ru)
PA (1) PA8495801A1 (ru)
PE (1) PE20010127A1 (ru)
PL (1) PL196867B1 (ru)
RS (1) RS50089B (ru)
SI (1) SI1181018T1 (ru)
SK (1) SK284590B6 (ru)
SV (1) SV2001000085A (ru)
TN (1) TNSN00112A1 (ru)
TR (1) TR200103392T2 (ru)
TW (1) TWI263498B (ru)
UA (1) UA59491C2 (ru)
UY (1) UY26166A1 (ru)
WO (1) WO2000072847A1 (ru)
ZA (1) ZA200109692B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175855B1 (en) 1999-05-27 2007-02-13 Pfizer Inc. Ziprasidone suspension
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
PL377679A1 (pl) * 2002-10-25 2006-02-06 Pfizer Products Inc. Nowe preparaty typu depot do wstrzykiwania
RU2292207C2 (ru) * 2002-10-25 2007-01-27 Пфайзер Продактс Инк. Депо-препараты арилгетероциклических активных веществ в виде суспензии
EP1418492B1 (en) 2002-11-05 2017-09-20 LG Electronics, Inc. Touch screen mounting assembly for LCD monitor
WO2005040160A2 (en) 2003-10-24 2005-05-06 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
EP1744750A2 (en) 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1753400A4 (en) * 2004-06-11 2012-11-28 Reddys Lab Ltd Dr PHARMACEUTICAL FOR ZIPRASIDONE
US20080268034A1 (en) * 2005-01-07 2008-10-30 Girish Karanth Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
AU2006285349A1 (en) * 2005-06-20 2007-03-08 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds
US9198862B2 (en) 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations

Also Published As

Publication number Publication date
CZ20014230A3 (cs) 2002-08-14
CO5170458A1 (es) 2002-06-27
CA2371550C (en) 2007-01-02
CU23223B7 (es) 2007-08-30
BG65367B1 (bg) 2008-04-30
AU4138500A (en) 2000-12-18
ATE234097T1 (de) 2003-03-15
EE200100633A (et) 2003-02-17
EE04704B1 (et) 2006-10-16
EA003907B1 (ru) 2003-10-30
SK16782001A3 (sk) 2002-09-10
OA11946A (en) 2006-04-13
GT200000081A (es) 2001-11-16
SK284590B6 (sk) 2005-07-01
ZA200109692B (en) 2002-11-26
HN2000000071A (es) 2001-02-02
CN1352560A (zh) 2002-06-05
KR100477782B1 (ko) 2005-03-21
AR022643A1 (es) 2002-09-04
SV2001000085A (es) 2001-11-08
PA8495801A1 (es) 2001-12-14
EP1181018A1 (en) 2002-02-27
IS6134A (is) 2001-10-30
BR0010990A (pt) 2002-03-05
NO20015755D0 (no) 2001-11-26
KR20020048307A (ko) 2002-06-22
NO20015755L (no) 2002-01-23
DE60001649T2 (de) 2003-08-21
AP2001002346A0 (en) 2001-12-31
CR6506A (es) 2004-03-24
JP2003500449A (ja) 2003-01-07
ES2191618T3 (es) 2003-09-16
HUP0201297A3 (en) 2005-09-28
TR200103392T2 (tr) 2002-11-21
GC0000190A (en) 2006-03-29
DE60001649D1 (de) 2003-04-17
HRP20010878A2 (en) 2003-06-30
NO320296B1 (no) 2005-11-21
PL196867B1 (pl) 2008-02-29
MY127891A (en) 2006-12-29
WO2000072847A1 (en) 2000-12-07
GEP20033113B (en) 2003-11-25
TWI263498B (en) 2006-10-11
EP1181018B1 (en) 2003-03-12
DK1181018T3 (da) 2003-04-22
PE20010127A1 (es) 2001-02-06
PL352826A1 (en) 2003-09-08
HK1046366B (zh) 2005-07-29
TNSN00112A1 (fr) 2005-11-10
IL145950A (en) 2007-12-03
NZ514764A (en) 2004-04-30
JP3942827B2 (ja) 2007-07-11
DZ3049A1 (fr) 2004-03-27
UY26166A1 (es) 2000-12-29
IS2396B (is) 2008-08-15
HRP20010878B1 (en) 2007-03-31
CA2371550A1 (en) 2000-12-07
RS50089B (sr) 2009-01-22
MA26741A1 (fr) 2004-12-20
AU777413B2 (en) 2004-10-14
SI1181018T1 (en) 2003-06-30
BG106153A (bg) 2002-06-28
IL145950A0 (en) 2002-07-25
HUP0201297A2 (en) 2002-08-28
UA59491C2 (ru) 2003-09-15
CN1196486C (zh) 2005-04-13
MXPA01012124A (es) 2002-06-04
AP1409A (en) 2005-06-13
HK1046366A1 (en) 2003-01-10
YU76701A (sh) 2005-07-19

Similar Documents

Publication Publication Date Title
EA200101131A1 (ru) Суспензия зипразидона
AU1497692A (en) Sulfonamides and their medical use
DE60024115D1 (de) Pharmazeutisch wirksamer sulfonamid derivaten
NO20025590D0 (no) Fenylglycin-derivater
DE69925133D1 (de) Pyrrolobenzodiazepine
ATE289478T1 (de) Ektoparasitizide wässrige suspensionsformulierungen von spinosynen
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
EA200300883A1 (ru) Агрохимическая композиция
ES2172217T3 (es) Suspensiones de furoato de mometasona para nebulizacion.
JO2181B1 (en) Procalopride solution is taken by mouth
TR199900730T2 (xx) S�v� alendronat form�lasyonlar�
WO2002076376A3 (en) A stable pharmaceutical composition of pravastatin
EA200201232A1 (ru) Производные сульфонамида
EA200200042A1 (ru) Стабильный раствор ксилометазолина и оксиметазолина
EA200201234A1 (ru) Производные сульфонамида
EA200300505A1 (ru) Агрохимическая композиция
ECSP003496A (es) Suspensión de ziprasidona
RU2001109481A (ru) Антиангинальное средство
UA33865A (uk) Дикалієва сіль n-сукцин - dl-триптофану, що має антиангінальну та антигіпоксантну дію
CA2485132A1 (en) Pipe protector
RU97110934A (ru) Циклогексиламид хинолино[2,1-b]хиназолин-12-он-5-карбоновой кислоты, проявляющий антифлавирусную активность
HN1999000201A (es) Derivados de 3,3 biarilpiperidina y 2,2 - biarilmorfolina
ITTO991134A0 (it) Corpo luminescente per un tronco di sommita' di un palo di illuminazio ne stradale.
IT1308158B1 (it) Chiasma ferroviario.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU